NCT01933841View on ClinicalTrials.gov

The Impact of Quantitative Neuromuscular Monitoring in the PACU on Residual Blockade and Postoperative Recovery

CompletedOBSERVATIONAL

Enrollment

201

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions

Muscle Weakness

Interventions

DEVICE

TOF-Watch SX

As part of standard care, patients who undergo intraoperative neuromuscular blockade will have their TOF ratio measured and recorded during their first 10 minutes in the PACU by perioperative nursing staff.

PROCEDURE

Notify the provider

"Based on the TOF reading, the patient's PACU nurse will page the provider who administered the block and/or a designated Reversal Support team member. The page will identify the patient and notify the provider of the suboptimal TOF ratio."

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors

lead

Vanderbilt University Medical Center

OTHER

NCT01933841 - The Impact of Quantitative Neuromuscular Monitoring in the PACU on Residual Blockade and Postoperative Recovery | Biotech Hunter | Biotech Hunter